Profound Medical (PROF) Price to Sales (2024 - 2026)

Profound Medical has reported Price to Sales for 3 years, with the latest figure at 97.84 in Q2 2026.

• On a quarterly basis, Price to Sales rose 22.0% year-over-year to 97.84 in Q2 2026; TTM through Jun 2026 was 12.73, a 15.0% decrease from a year earlier, with the FY2025 full-year figure at 14.78, down 15.13% from the prior year.
• Price to Sales was 97.84 for Q2 2026 at Profound Medical, up from 44.12 in the prior quarter.
• The five-year high for Price to Sales was 144.02 in Q1 2024, with the low at 27.92 in Q3 2025.
• Average Price to Sales over 3 years is 70.6, with a median of 67.85 recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Price to Sales slumped 59.52% in 2025, then grew 22.0% in 2026.
• Over 3 years, Price to Sales stood at 44.54 in 2024, then retreated by 10.62% to 39.81 in 2025, then surged by 145.78% to 97.84 in 2026.
• The last three Price to Sales figures came in at 97.84 (Q2 2026), 44.12 (Q1 2026), and 39.81 (Q4 2025), per Business Quant data.